Johnson & Johnson has agreed to acquire Intra-Cellular Therapies for approximately $14.6 billion, in the largest biopharma merger-and-acquisition (M&A) deal announced in two years.

Scripps Research chemists unlock the potential of ketone and ester molecules, paving the way for greener and more efficient ...

Experiments showed that when mitochondrial protein MCJ is removed from obese mice the animals produce more heat and lose ...

EY—the professional services firm originally known as Ernst & Young—reports the dollar value of biopharma M&A deals nosedived ...

Investors sell off AMD shares despite the company's pivot to life sciences AI, following a rating downgrade by HSBC that followed a six-month decline in the stock price.

Samsung’s ADC segregated suite, equipped with a 500-liter reactor, supports the development and manufacture of ADC therapies.

View eBook In the rapidly developing field of spatial biology, researchers are working to expand our understanding of ...

Intravenous BCG vaccine with a built-in kill-switch was found to be at least as effective as regular tuberculosis vaccine in protecting monkeys against infection.

The adenine base editor corrected the most common mutation associated with Stargardt disease in the ABCA4 gene with no off-target effects.

A new predictive AI system has been developed to predict gene activity in human cells with high precision. Researchers at Columbia University Vagelos College of Physicians and Surgeons, led by Raul ...